Issue 16, 2025

The therapeutic potential of pomegranate in the prevention and management of noncommunicable diseases

Abstract

Noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, respiratory conditions, and metabolic and central nervous system disorders, are the leading causes of morbidity and mortality worldwide. These diseases are primarily driven by unhealthy diets and sedentary lifestyles. Pomegranate (Punica granatum L.), a fruit rich in diverse functional phytoconstituents, has emerged as a promising natural therapeutic agent for the prevention and management of NCDs. Every part of the fruit harbors distinct bioactive compounds that contribute to its health-promoting properties. The peels are particularly rich in punicalagins, the arils are abundant in anthocyanins and ellagic acid, and the seeds contain significant amounts of punicic acid, ellagic acid, and quercetin. Pomegranate peel extracts and juice demonstrate cardioprotective effects through inhibition of angiotensin-converting enzyme (ACE) activity, reduction of inflammatory cytokines, e.g., interleukins and TNF-α, and improvements in lipid profiles. Additionally, their anticancer properties are associated with the upregulation of pro-apoptotic markers (Bax, cytochrome c, caspases 3 and 9, and p53) and the downregulation of tumor-promoting and inflammatory markers (Bcl-2, MMP-2, MMP-9, GOLPH-3, and N-cadherin), as well as the attenuation of reactive oxygen species (ROS) generation. Moreover, pomegranate extracts have exhibited hypoglycemic, nephroprotective, hepatoprotective, antidepressant, anti-Alzheimer's, and anti-Parkinson's properties, as demonstrated in in vitro and in vivo studies, and clinical trials. Recent investigations have identified key bioactive constituents, including punicalagin, ellagic acid, gallic acid, and urolithin A, as major contributors to these therapeutic effects. This review provides an overview of the metabolomic profile of pomegranate, its therapeutic potential, safety, and quality control assessments, and strategies to enhance the stability and bioavailability of its active constituents, thus underscoring its potential as a natural intervention for the prevention and treatment of NCDs.

Graphical abstract: The therapeutic potential of pomegranate in the prevention and management of noncommunicable diseases

Article information

Article type
Review Article
Submitted
02 May 2025
Accepted
11 Jul 2025
First published
29 Jul 2025

Food Funct., 2025,16, 6313-6345

The therapeutic potential of pomegranate in the prevention and management of noncommunicable diseases

A. U. Rahman, M. Esa and P. Panichayupakaranant, Food Funct., 2025, 16, 6313 DOI: 10.1039/D5FO01999K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements